Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
The Bill & Melinda Gates Foundation
Biotech
Pfizer steers group B strep vax to ph. 3 immunogenicity study
Given the challenges of running an efficacy study for a group B strep vaccine, Pfizer hopes an immunogenicity study will do for approval instead.
Max Bayer
Aug 24, 2023 11:45am
Bill & Melinda Gates research arm picks up 2 Merck TB candidates
Oct 18, 2022 11:00am
Illumina pledges $60M to new global outbreak-tracking network
Apr 28, 2021 10:48am
Novartis, Gates Foundation ally on sickle cell gene therapy
Feb 17, 2021 8:55am
Big Pharma companies join forces for fightback against COVID-19
Mar 27, 2020 8:30am
NIH, Gates Foundation commit $200M to cure HIV, sickle cell
Oct 24, 2019 8:35am